Symptom severity 1 to 4 months after thoracotomy for lung cancer

American Journal of Critical Care

Volumn 17, Issue 5, 2008, Pages 455-467

  Sarna, Linda ^a   Cooley, Mary E ^b   Brown, Jean K ^c   Chernecky, Cynthia ^d   Elashoff, David ^e   Kotlerman, Jenny ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DEMOGRAPHY; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SEX DIFFERENCE; THORACOTOMY; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CRITICAL CARE; DEMOGRAPHY; FEMALE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; THORACOTOMY; TIME FACTORS;

EID: 58149137169     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Ginsberg MS, Grewal RK, Heelan RT. Lung cancer. Radiol Clin North Am. 2007;45:21-43.
2. Dales RE, Belanger R, Shamji FM, Leech J, Crepeau A, Sachs HJ. Quality of life following thoracotomy for lung cancer. J Clin Epidemiol. 1994;47:1443-1449.
3. Zieren HU, Müller JM, Hamberger U, Pichlmaier H. Quality of life after surgical therapy of bronchogenic carcinoma. Eur J Cardiothor Surg. 1996;10(4)233-237.
4. Myrdal G, Valtysdottir S, Lambe M, Strahle E. Quality of life following lung cancer surgery. Thorax. 2003;58:194-197.
5. Brunelli A, Socci L, Refai M, Salati M, Xiume F, Sabbatini A. Quality of life before and after major lung resection for lung cancer: a prospective follow-up analysis. Ann Thorac Surg. 2007;84:410-416.
6. Barlési F, Doddoli C, Loundou A, Pillet E, Thomas P, Auquier P. Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery. Eur J Cardiothorac Surg. 2006;30(3):548-553.
7. Win T, Sharples L, Wells FC, Ritchie AJ, Munday H, Laroche CM. Effect of lung cancer surgery on quality of life. Thorax. 2005;60:234-238.
8. Sarna L, Reidinger MS. Assessment of quality of life and symptom improvement in lung cancer clinical trials. Semin Oncol. 2004;31(suppl 9):1-10.
9. Cooley ME, Short TH, Moriatry HJ. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology. 2003;12(7):694-708.
10. Earl C. Outcomes research in lung cancer. J Natl Cancer Inst Monogr. 2004;33:56-77.
11. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health. 1998;52(3):203-204.
12. Mangione CM, Goldman L, Orav EJ, et al. Health-related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med. 1997;12(11):686-697.
13. Handy JR Jr, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest. 2002;122(1):21-30.
14. Bolliger CT, Jordan P, Solèr M. et al. Pulmonary function and exercise capacity after lung resection. Eur Respir J. 1996;9(3):415-421.
15. Gotoda Y, Kambara N, Sakai T, et al. The morbidity, time course and predictive factors for persistent post-thoracotomy pain. Eur J Pain. 2001;5(1):89-96.
16. Rogers ML, Duffy JP. Surgical aspects of chronic post-thoracotomy pain. Eur J Cardiothorac Surg. 2000;18(6):711-716.
17. Sarna L, Evangelista L, Tashkin D, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004;125(2):439-445.
18. Given B, Given C, Azzouz, F, Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial assessment. Nurs Res. 2001;50:222-232.
19. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19-28.
20. Uchitomi Y, Mikami I, Kugaya A, et al. Depression after successful treatment for nonsmall cell lung carcinoma. Cancer. 2000;89(5):1172-1179.
21. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small cell lung cancer. J Clin Oncol. 2002;20(13):2920-2929.
22. Dodd MJ, Miaskowski C, Paul S. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28:465-470.
23. Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middlerange theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19(3):14-27.
24. Sarna L, Brown JK, Cooley ME, et al. Quality of life and meaning of illness of women with lung cancer. Oncol Nurs Forum. 2005;32(1):E9-E19.
25. Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004;126(6):1733-1741.
26. Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors. J Clin Oncol. 2000;18:893-903.
27. Nugent AM, Steele IC, Carragher AM, et al. Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer. Thorax. 1999;54(4):334-338.
28. Hendriks J, Van Schil P, Van Meerbeeck J, et al. Short-term survival after major pulmonary resections for bronchogenic carcinoma. Acta Chir Belg. 1996;96(6):273-279.
29. Li WW, Lee TW, Lam SS, et al. Quality of life following lung cancer resection: video-assisted thoracic surgery vs thoracotomy. Chest. 2002;122(2)584-589.
30. Li WW, Lee TW, Yim AP. Quality of life after lung cancer resection. Thorac Surg Clin. 2004;14(3):353-365.
31. Garzon JC, Ng CS, Lee TW, Yim AP. Video-assisted thoracic surgery pulmonary resection for lung cancer patients with poor lung function. Ann Thorac Surg. 2006;81:1996-2003.
32. Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev. 2005;31(5):380-402.
33. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007; 57:253-260.
34. Licker MJ, Widikker I, Robert J, et al. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006;81(5):1830-1837.
35. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2287-2293.
36. Evangelista LS, Sarna L, Brecht ML, Padilla G, Chen J. Health perceptions and risk behaviors of lung cancer survivors. Heart Lung. 2003;32(2):131-139.
37. Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr. 2004;32:17-21.
38. Hollen PJ, Gralla RJ, Kris MG, Eberly SW, Cox C. Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer. 1999;7(3):140-148.
39. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993; 29A(suppl 1):S51-S58.
40. Hollen PJ, Gralla RJ. Comparison of instruments to measure quality of life in patients with lung cancer. Semin Oncol. 1995;23(2 suppl):31-40.
41. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research: how meaningful is it? Pharmacoeconomics. 2000;18(5):419-423.
42. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis. 1978;118(6,pt2):1-120.
43. Eakin EG, Sass-Dambron DE, Ries AL, Kaplan RM. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med. 1995;2(2):118-134.
44. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17(2):197-210.
45. Schwartz A, Meek P. Additional content validity of the Schwartz Cancer Fatigue Scale. J Nurs Meas. 1999;7(1):35-45.
46. Schwartz AL. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum. 1998;25(4):711-717.
47. Schwartz A. Manual of Instructions for the Schwartz Cancer Fatigue Scale (SCFS). Portland, OR: Oregon Health Sciences Center; 1997.
48. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401.
49. Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:80-92.
50. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-383.
51. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73-84.
52. Holtzman D, Powell-Griner E, Bolen JC, Rhodes L. Stateand sex-specific prevalence of selected characteristics- Behavioral Risk Factor Surveillance System, 1996 and 1997. MMWR CDC Surveill Summ. 2000;49(6):1-39.
53. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3(3-4):235-241.
54. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med. 1989;12(2):159-182.
55. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159.
56. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998; 22(1):39-47.
57. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Springer Business + Science Media; 2002.
58. Hollen P, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer. 1994;73(8):2087-2098.
59. Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76-78.
60. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptoms reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7(11): 903-909.
61. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: US Department of Public Health, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
62. Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991;2(2): 105-112.
63. Walker MS, Larsen RJ, Zona DM, Govindan R, Fisher EB. Smoking urges and relapse among lung cancer patients: findings from a preliminary retrospective study. Prev Med. 2004;39(3):449-457.
64. Alam N, Darling G, Evans WK, et al. Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review. Crit Rev Oncol Hematol. 2006;58(2):146-155.